Proventa Medicinal Chemistry Meeting
Using innovative modalities, researchers are making rapid progress in developing therapeutics against targets previously considered to be undruggable. Join WuXi AppTec in roundtable discussions hosted by Proventa. Learn about recent advances in the use of bifunctional molecules, antisense oligonucleotides, and screening approaches to identify covalent inhibitors and small molecule ligands of RNA.
| Keynote Speaker and Roundtable Chair |
| Enabling and Accelerating Innovative and Emerging Modalities Drug Discovery Dr. Tao Guo, Senior Vice President and Head of WuXi Chemistry, WuXi AppTec |
| Round Table Chair | Hit Identification and Lead Optimization |
| Hit Identification Technologies and Cracking Undruggable Targets - Which Technology to Choose? Andreas Schoop, PhD, Head of Medicinal Chemistry, WuXi AppTec |
